N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide

C131H148N32O6 — CID 159033796

IUPACN-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide
SMILESCN1CCC(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)CC1.Cn1cnc(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)c1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccc2nccnc2c1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccncc1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1cocn1
InChIInChI=1S/C29H29N7O.C27H36N6O.C26H28N6O.C25H29N7O.C24H26N6O2/c37-29(20-9-13-23-26(18-20)31-17-16-30-23)34-22-10-6-19(7-11-22)8-12-24-27-25(36-35-24)14-15-32-28(27)33-21-4-2-1-3-5-21;1-33-17-14-20(15-18-33)27(34)30-22-10-7-19(8-11-22)9-12-23-25-24(32-31-23)13-16-28-26(25)29-21-5-3-2-4-6-21;33-26(19-12-15-27-16-13-19)30-21-9-6-18(7-10-21)8-11-22-24-23(32-31-22)14-17-28-25(24)29-20-4-2-1-3-5-20;1-32-15-22(27-16-32)25(33)29-19-10-7-17(8-11-19)9-12-20-23-21(31-30-20)13-14-26-24(23)28-18-5-3-2-4-6-18;31-24(21-14-32-15-26-21)28-18-9-6-16(7-10-18)8-11-19-22-20(30-29-19)12-13-25-23(22)27-17-4-2-1-3-5-17/h6-7,9-11,13-18,21H,1-5,8,12H2,(H,32,33)(H,34,37)(H,35,36);7-8,10-11,13,16,20-21H,2-6,9,12,14-15,17-18H2,1H3,(H,28,29)(H,30,34)(H,31,32);6-7,9-10,12-17,20H,1-5,8,11H2,(H,28,29)(H,30,33)(H,31,32);7-8,10-11,13-16,18H,2-6,9,12H2,1H3,(H,26,28)(H,29,33)(H,30,31);6-7,9-10,12-15,17H,1-5,8,11H2,(H,25,27)(H,28,31)(H,29,30)
InChIKeyJVFAFCKYKCTWLG-UHFFFAOYSA-N
MW2266.84 g/mol
LogP24.79
Rot. Bonds35

About N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide

N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide (PubChem CID 159033796) has the molecular formula C131H148N32O6 and a molecular weight of 2266.84 g/mol. Its IUPAC name is N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide.

Molecular Properties

Compound NameN-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide
PubChem CID159033796
Molecular FormulaC131H148N32O6
Molecular Weight2266.84 g/mol
Exact Mass2265.23
IUPAC NameN-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide
SMILESCN1CCC(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)CC1.Cn1cnc(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)c1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccc2nccnc2c1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccncc1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1cocn1
InChIInChI=1S/C29H29N7O.C27H36N6O.C26H28N6O.C25H29N7O.C24H26N6O2/c37-29(20-9-13-23-26(18-20)31-17-16-30-23)34-22-10-6-19(7-11-22)8-12-24-27-25(36-35-24)14-15-32-28(27)33-21-4-2-1-3-5-21;1-33-17-14-20(15-18-33)27(34)30-22-10-7-19(8-11-22)9-12-23-25-24(32-31-23)13-16-28-26(25)29-21-5-3-2-4-6-21;33-26(19-12-15-27-16-13-19)30-21-9-6-18(7-10-21)8-11-22-24-23(32-31-22)14-17-28-25(24)29-20-4-2-1-3-5-20;1-32-15-22(27-16-32)25(33)29-19-10-7-17(8-11-19)9-12-20-23-21(31-30-20)13-14-26-24(23)28-18-5-3-2-4-6-18;31-24(21-14-32-15-26-21)28-18-9-6-16(7-10-18)8-11-19-22-20(30-29-19)12-13-25-23(22)27-17-4-2-1-3-5-17/h6-7,9-11,13-18,21H,1-5,8,12H2,(H,32,33)(H,34,37)(H,35,36);7-8,10-11,13,16,20-21H,2-6,9,12,14-15,17-18H2,1H3,(H,28,29)(H,30,34)(H,31,32);6-7,9-10,12-17,20H,1-5,8,11H2,(H,28,29)(H,30,33)(H,31,32);7-8,10-11,13-16,18H,2-6,9,12H2,1H3,(H,26,28)(H,29,33)(H,30,31);6-7,9-10,12-15,17H,1-5,8,11H2,(H,25,27)(H,28,31)(H,29,30)
InChIKeyJVFAFCKYKCTWLG-UHFFFAOYSA-N
XLogP24.79
TPSA499.26 Ų
H-Bond Donors15
H-Bond Acceptors28
Rotatable Bonds35
Heavy Atoms169
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002266.84
LogP ≤ 524.79
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1028

Analyze N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(1,1-dideuterioethyl)-5-propan-2-ylisoquinolin-1-one;2-(difluoromethyl)-5-propan-2-ylisoquinolin-1-one;2,5-di(propan-2-yl)isoquinolin-1-one;2-ethyl-5-propan-2-ylisoquinolin-1-one;2-(2-fluoropropyl)-5-propan-2-ylisoquinolin-1-one;1-methyl-2-methylidene-5-propan-2-ylquinoline;1-methyl-7-propan-2-ylbenzimidazole;2-methyl-5-propan-2-yl-3,4-dihydroisoquinolin-1-one;1-methyl-7-propan-2-ylindazole;3-methyl-4-propan-2-yl-2H-indazole;2-methyl-5-propan-2-ylisoquinolin-1-one;4-methyl-5-propan-2-yl-1,3-oxazole;1-methyl-5-propan-2-ylpyrazole;3-methyl-8-propan-2-ylquinazolin-4-one;5-propan-2-yl-3,4-dihydro-2H-naphthalen-1-one;4-propan-2-yl-1H-indazole;5-propan-2-yl-2H-naphthalen-1-one;5-propan-2-yl-2-(2,2,2-trifluoroethyl)-3,4-dihydroisoquinolin-1-one
CID 158594192
3-anilino-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[4-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;2-phenyl-N-[4-[6-(piperidin-1-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrrol-3-yl]benzamide
CID 159174326
3-anilino-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]pyridine-2-carboxamide;2-(benzylamino)-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]benzamide;2-methyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-4-(trifluoromethyl)-1,3-oxazole-5-carboxamide;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-phenylbenzamide
CID 159268866
4-acetamido-N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-2-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-3-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide
CID 158288240
1-(4-fluorophenyl)-N-[(1S)-1-[2-[methyl(piperidin-4-yl)amino]-4-pyridinyl]propyl]pyrazolo[5,4-c]pyridine-4-carboxamide;2-[1-[[1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carbonyl]amino]propyl]-N-methyl-1,3-oxazole-4-carboxamide;2-[1-[[1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carbonyl]amino]propyl]-1,3-oxazole-4-carboxamide;1-(4-fluorophenyl)-N-[(1R)-1-(1H-pyrazol-4-yl)propyl]pyrazolo[5,4-c]pyridine-4-carboxamide;methyl 2-[1-[[1-(4-fluorophenyl)pyrazolo[5,4-c]pyridine-4-carbonyl]amino]propyl]-1,3-oxazole-4-carboxylate
CID 159431286
4,6-dimethyl-N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-2-oxo-1H-pyridine-3-carboxamide;1-(2-ethyl-5-methylpyrimidin-4-yl)-2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]ethanone;2-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-1-piperidin-4-ylethanone;N-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-7H-pyrrolo[1,2-a]imidazole-2-carboxamide
CID 160501112
3-chloro-N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]benzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]cyclopentanecarboxamide;[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-(4-methylpiperidin-1-yl)methanone;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-4-morpholin-4-ylbenzamide;N-[3-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide
CID 160503466
2-amino-9-propan-2-yl-1H-purin-6-one;bis(5-propan-2-yl-1,3-dihydroindol-2-one);bis(6-propan-2-yl-1,3-dihydroindol-2-one);6-propan-2-yl-3,4-dihydro-2H-isoquinolin-1-one;bis(5-propan-2-yl-1H-indazole);bis(6-propan-2-yl-1H-indazole);bis(5-propan-2-yl-1H-indole);bis(6-propan-2-yl-1H-indole);6-propan-2-ylisoquinoline;6-propan-2-yl-2H-isoquinolin-1-one;7-propan-2-yl-5H-pyrrolo[3,2-d]pyrimidine;6-propan-2-ylquinazoline;6-propan-2-ylquinoline;6-propan-2-ylquinoxaline
CID 160576804
[(2S)-2-[5-[(3S)-3-aminopyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]-cinnolin-4-ylmethanone;[(2S)-2-[5-[(3S)-3-aminopyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]-(1-methylbenzotriazol-5-yl)methanone;[(2S)-2-[5-[(3S)-3-aminopyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]-(4-methyl-1,3-oxazol-5-yl)methanone;[(2S)-2-[5-[(3S)-3-aminopyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]-(3-methyl-2-pyridinyl)methanone;[(2S)-2-[5-[(3S)-3-aminopyrrolidin-1-yl]-6-methylpyrazolo[1,5-a]pyrimidin-2-yl]piperidin-1-yl]-(4-pyridin-3-ylphenyl)methanone
CID 160850511
[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-morpholin-4-ylmethanone;1-[3-[2-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-2-oxoethyl]phenyl]propan-2-one;1-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-2-pyridin-4-ylethanone;1-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-2-quinoxalin-6-ylethanone;3-[3-oxo-3-[(3R)-3-phenylpiperidin-1-yl]propyl]-2,5-dihydropyrazolo[4,3-c]pyridin-4-one
CID 161342365
1-methyl-4-propan-2-ylbenzimidazole;1-methyl-7-propan-2-ylbenzimidazole;1-methyl-7-propan-2-ylbenzotriazole;2-methyl-5-propan-2-yl-3,4-dihydroisoquinolin-1-one;1-methyl-7-propan-2-ylindazole;2-methyl-7-propan-2-ylindazole;3-methyl-4-propan-2-yl-2H-indazole;4-methyl-5-propan-2-yl-1,3-oxazole;1-methyl-5-propan-2-ylpyrazole;1-methyl-4-propan-2-ylpyrrolo[2,3-b]pyridine;5-propan-2-yl-3,4-dihydro-2H-naphthalen-1-one;4-propan-2-yl-1H-indazole;5-propan-2-ylisoquinoline;8-propan-2-ylisoquinoline;4-propan-2-yl-2,7-naphthyridine;3-propan-2-ylpyrazolo[1,5-b]pyridazine;5-propan-2-ylquinoline;8-propan-2-ylquinoline
CID 161778501
N-[2-[4-amino-7-(1H-pyrazol-5-yl)-1H-pyrrolo[3,2-c]quinolin-2-yl]ethyl]-6-tert-butylpyridine-2-carboxamide;2-[2-[1-(1-methylimidazol-4-yl)ethenylamino]ethyl]-7-(1H-pyrazol-5-yl)-1H-pyrrolo[3,2-c]quinolin-4-amine;2-[2-[1-(1,3-oxazol-5-yl)ethenylamino]ethyl]-7-(1H-pyrazol-5-yl)-1H-pyrrolo[3,2-c]quinolin-4-amine
CID 161798991

Frequently Asked Questions

What is the IUPAC name of N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide?
The IUPAC name of N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide (CID 159033796) is N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide.
What is the SMILES notation for N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide?
The canonical SMILES for N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide is CN1CCC(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)CC1.Cn1cnc(C(=O)Nc2ccc(CCc3[nH]nc4ccnc(NC5CCCCC5)c34)cc2)c1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccc2nccnc2c1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1ccncc1.O=C(Nc1ccc(CCc2[nH]nc3ccnc(NC4CCCCC4)c23)cc1)c1cocn1.
What is the InChIKey of N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide?
The InChIKey is JVFAFCKYKCTWLG-UHFFFAOYSA-N. The full InChI is InChI=1S/C29H29N7O.C27H36N6O.C26H28N6O.C25H29N7O.C24H26N6O2/c37-29(20-9-13-23-26(18-20)31-17-16-30-23)34-22-10-6-19(7-11-22)8-12-24-27-25(36-35-24)14-15-32-28(27)33-21-4-2-1-3-5-21;1-33-17-14-20(15-18-33)27(34)30-22-10-7-19(8-11-22)9-12-23-25-24(32-31-23)13-16-28-26(25)29-21-5-3-2-4-6-21;33-26(19-12-15-27-16-13-19)30-21-9-6-18(7-10-21)8-11-22-24-23(32-31-22)14-17-28-25(24)29-20-4-2-1-3-5-20;1-32-15-22(27-16-32)25(33)29-19-10-7-17(8-11-19)9-12-20-23-21(31-30-20)13-14-26-24(23)28-18-5-3-2-4-6-18;31-24(21-14-32-15-26-21)28-18-9-6-16(7-10-18)8-11-19-22-20(30-29-19)12-13-25-23(22)27-17-4-2-1-3-5-17/h6-7,9-11,13-18,21H,1-5,8,12H2,(H,32,33)(H,34,37)(H,35,36);7-8,10-11,13,16,20-21H,2-6,9,12,14-15,17-18H2,1H3,(H,28,29)(H,30,34)(H,31,32);6-7,9-10,12-17,20H,1-5,8,11H2,(H,28,29)(H,30,33)(H,31,32);7-8,10-11,13-16,18H,2-6,9,12H2,1H3,(H,26,28)(H,29,33)(H,30,31);6-7,9-10,12-15,17H,1-5,8,11H2,(H,25,27)(H,28,31)(H,29,30).
What are the key properties of N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide?
N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide has a molecular weight of 2266.84 g/mol, XLogP of 24.79, 35 rotatable bonds, 15 hydrogen bond donors, and 28 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylimidazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1-methylpiperidine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]-1,3-oxazole-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]pyridine-4-carboxamide;N-[4-[2-[4-(cyclohexylamino)-2H-pyrazolo[4,3-c]pyridin-3-yl]ethyl]phenyl]quinoxaline-6-carboxamide is sourced from PubChem (CID 159033796), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).